Literature DB >> 1396882

Short stature with normal growth hormone and elevated IGF-I.

T Momoi1, C Yamanaka, M Kobayashi, T Haruta, H Sasaki, T Yorifuji, M Kaji, H Mikawa.   

Abstract

We report on a Japanese girl with short stature, malar hypoplasia, up-slanting palpebral fissures, blue sclerae and thin, stiff and slightly brownish hair. Short stature started in utero and her psychomotor development was normal. Menarche appeared at 13 years 8 months. Height at 14 years 5 months was 132 cm (-4.6 SD). Her growth hormone (GH) sleep pattern and responses to insulin, L-dopa, arginine, propranolol-glucagon and growth hormone-releasing hormone were normal. Plasma insulin-like growth factor I (IGF-I) was high (2170-4860 units/l) and increased from 4860 to 7080 units/l 20 h after biosynthetic GH injection. Gel infiltration patterns of the free and protein-bound IGF-I in plasma from the patient were not different from the controls; IGF-I fraction of the high and low molecular weight binding protein and the non-protein bound fraction were 75.5%, 15.8% and 8.7%, respectively. IGF-I from the patient showed normal bioactivities when determined by [35S]sulphate and [3H]thymidine uptake into cultured rat chondrocytes, and by [3H]thymidine and [3H]alpha-aminoisobutyric acid uptake into the patient's skin fibroblasts. IGF-I binding to cultured skin fibroblasts from the patient was comparable to that of controls. These results suggest that tissue specific defects of IGF-I receptors may be the cause of increased IGF-I levels in the patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396882     DOI: 10.1007/bf02113248

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Chemical synthesis, cloning, and expression of genes for human somatomedin C (insulin-like growth factor I) and 59Val-somatomedin C.

Authors:  M Niwa; S Sato; Y Saito; F Uchiyama; H Ono; M Yamashita; T Kitaguchi; Y Shiga; J Notani; H Yamada
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

2.  Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation.

Authors:  P Freychet; R Kahn; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

3.  An improved fluorometric assay for DNA.

Authors:  R T Hinegardner
Journal:  Anal Biochem       Date:  1971-01       Impact factor: 3.365

4.  Effect of in vitro action of serum proteases or exposure to acid on measurable immunoreactive somatomedin-C in serum.

Authors:  P G Chatelain; J Van Wyk; K C Copeland; S L Blethen; L E Underwood
Journal:  J Clin Endocrinol Metab       Date:  1983-02       Impact factor: 5.958

5.  Cartilage-derived factor (CDF) I. Stimulation of proteoglycan synthesis in rat and rabbit costal chondrocytes in culture.

Authors:  Y Kato; Y Nomura; Y Daikuhara; N Nasu; M Tsuji; A Asada; F Suzuki
Journal:  Exp Cell Res       Date:  1980-11       Impact factor: 3.905

6.  Low levels of high-affinity growth hormone-binding protein in African pygmies.

Authors:  G Baumann; M A Shaw; T J Merimee
Journal:  N Engl J Med       Date:  1989-06-29       Impact factor: 91.245

7.  Osteogenesis by chondrocytes from growth cartilage of rat rib.

Authors:  Y Shimomura; T Yoneda; F Suzuki
Journal:  Calcif Tissue Res       Date:  1975-12-22

8.  Measurement of insulin-like growth factor I (IGF-I) responsiveness of fibroblasts of children with short stature: identification of a patient with IGF-I resistance.

Authors:  E Heath-Monnig; H J Wohltmann; B Mills-Dunlap; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1987-03       Impact factor: 5.958

9.  Serum insulin-like growth factor I (somatomedin-C) level in normal subjects from infancy to adulthood, pituitary dwarfs and normal variant short children.

Authors:  S Suwa; N Katsumata; H Maesaka; E Tokuhiro; S Yokoya
Journal:  Endocrinol Jpn       Date:  1988-12

10.  Clarification of signaling pathways mediated by insulin and insulin-like growth factor I receptors in fibroblasts from patients with specific defect in insulin receptor.

Authors:  T Sasaoka; M Kobayashi; Y Takata; O Ishibashi; M Iwasaki; Y Shigeta; K Goji; A Hisatomi
Journal:  Diabetes       Date:  1988-11       Impact factor: 9.461

View more
  3 in total

1.  Clinical examples of disturbed IGF signaling: intrauterine and postnatal growth retardation due to mutations of the insulin-like growth factor I receptor (IGF-IR) gene.

Authors:  W Kiess; J Kratzsch; E Keller; A Schneider; K Raile; J Klammt; B Seidel; A Garten; H Schmidt; R Pfäffle
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

2.  Radiographic abnormalities in Laron dwarfism.

Authors:  M Vasil; A Baxova; K Kozlowski
Journal:  Pediatr Radiol       Date:  1994

3.  Bone deficits in parenteral nutrition-dependent infants and children with intestinal failure are attenuated when accounting for slower growth.

Authors:  Stephanie S Appleman; Heidi J Kalkwarf; Alok Dwivedi; James E Heubi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-07       Impact factor: 2.839

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.